Instil Bio (TIL) Operating Expenses (2020 - 2026)

Instil Bio has reported Operating Expenses for 7 years, with the latest figure at $5.6 million in Q2 2026.

• On a quarterly basis, Operating Expenses fell 76.19% year-over-year to $5.6 million in Q2 2026; TTM through Jun 2026 was $37.2 million, a 58.45% decrease from a year earlier, with the FY2025 full-year figure at $78.6 million, up 6.85% from the prior year.
• Operating Expenses was $5.6 million for Q2 2026 at Instil Bio, down from $7.0 million in the prior quarter.
• The five-year high for Operating Expenses was $66.7 million in Q3 2023, with the low at $5.6 million in Q2 2026.
• Average Operating Expenses over 5 years is $30.6 million, with a median of $23.5 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses jumped 131.96% in 2022, then plunged 77.08% in 2023.
• Over 5 years, Operating Expenses stood at $56.8 million in 2022, then plunged by 77.08% to $13.0 million in 2023, then fell by 9.22% to $11.8 million in 2024, then retreated by 19.14% to $9.6 million in 2025, then tumbled by 41.6% to $5.6 million in 2026.
• The last three Operating Expenses figures came in at $5.6 million (Q2 2026), $7.0 million (Q1 2026), and $9.6 million (Q4 2025), per Business Quant data.